S&P 500   4,267.82 (-1.61%)
DOW   33,580.00 (-1.26%)
QQQ   354.05 (-1.55%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.02 (-0.76%)
NIO   8.41 (+0.72%)
BABA   85.94 (-1.47%)
AMD   95.66 (-1.77%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   109.98 (-1.56%)
DIS   80.08 (-1.15%)
AMC   7.97 (-2.09%)
PFE   32.53 (-1.36%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
S&P 500   4,267.82 (-1.61%)
DOW   33,580.00 (-1.26%)
QQQ   354.05 (-1.55%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.02 (-0.76%)
NIO   8.41 (+0.72%)
BABA   85.94 (-1.47%)
AMD   95.66 (-1.77%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   109.98 (-1.56%)
DIS   80.08 (-1.15%)
AMC   7.97 (-2.09%)
PFE   32.53 (-1.36%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
S&P 500   4,267.82 (-1.61%)
DOW   33,580.00 (-1.26%)
QQQ   354.05 (-1.55%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.02 (-0.76%)
NIO   8.41 (+0.72%)
BABA   85.94 (-1.47%)
AMD   95.66 (-1.77%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   109.98 (-1.56%)
DIS   80.08 (-1.15%)
AMC   7.97 (-2.09%)
PFE   32.53 (-1.36%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
S&P 500   4,267.82 (-1.61%)
DOW   33,580.00 (-1.26%)
QQQ   354.05 (-1.55%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.02 (-0.76%)
NIO   8.41 (+0.72%)
BABA   85.94 (-1.47%)
AMD   95.66 (-1.77%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   109.98 (-1.56%)
DIS   80.08 (-1.15%)
AMC   7.97 (-2.09%)
PFE   32.53 (-1.36%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
NYSE:TFX

Teleflex (TFX) Stock Forecast, Price & News

$199.89
-3.55 (-1.74%)
(As of 03:15 PM ET)
Compare
Today's Range
$199.77
$204.10
50-Day Range
$203.42
$258.85
52-Week Range
$182.65
$276.43
Volume
227,560 shs
Average Volume
306,949 shs
Market Capitalization
$9.39 billion
P/E Ratio
25.66
Dividend Yield
0.68%
Price Target
$268.92

Teleflex MarketRank™ Forecast

Analyst Rating
Hold
2.42 Rating Score
Upside/​Downside
33.1% Upside
$268.92 Price Target
Short Interest
Healthy
3.51% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.53mentions of Teleflex in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.83%
From $13.29 to $14.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.78 out of 5 stars

Medical Sector

45th out of 961 stocks

Surgical & Medical Instruments Industry

6th out of 98 stocks


TFX stock logo

About Teleflex (NYSE:TFX) Stock

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Price History

TFX Stock News Headlines

Piper Sandler Remains a Hold on Teleflex (TFX)
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Teleflex (NYSE: TFX)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
JMP Securities Reaffirms Their Buy Rating on Teleflex (TFX)
Q2 2023 Teleflex Inc Earnings Call
Teleflex (TFX) Tops Q2 Earnings and Revenue Estimates
Teleflex Inc Q2 Profit Increases, beats estimates
Teleflex: Flexing Its Muscles A Bit
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Company Calendar

Last Earnings
8/03/2023
Ex-Dividend for 9/15 Dividend
9/14/2023
Dividend Payable
9/15/2023
Today
9/26/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
15,500
Year Founded
1943

Price Target and Rating

Average Stock Price Forecast
$268.92
High Stock Price Forecast
$315.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+33.1%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
12 Analysts

Profitability

Net Income
$363.14 million
Pretax Margin
15.63%

Debt

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$17.99 per share
Book Value
$85.74 per share

Miscellaneous

Free Float
46,329,000
Market Cap
$9.49 billion
Optionable
Optionable
Beta
1.03

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Liam J. KellyMr. Liam J. Kelly (Age 56)
    Chairman, Pres & CEO
    Comp: $2M
  • Mr. Thomas E. Powell (Age 61)
    Exec. VP & CFO
    Comp: $1.04M
  • Mr. Cameron P. HicksMr. Cameron P. Hicks (Age 58)
    Corp. VP of HR & Communications
    Comp: $564.68k
  • Mr. Jay White (Age 49)
    Corp. VP & Pres of Global Commercial
    Comp: $866.86k
  • Mr. John R. Deren
    Corp. VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy
    VP & Chief Information Officer
  • Mr. John Hsu C.F.A.
    VP of Investor Relations
  • Mr. Daniel V. Logue (Age 49)
    Corp. VP, Gen. Counsel & Sec.
  • Mr. Howard Cyr
    Corp. VP & Chief Compliance Officer
  • Mr. Matt Tomkin
    VP of Corp. Devel.













TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TFX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TFX, but not buy additional shares or sell existing shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price forecast for 2023?

12 Wall Street analysts have issued twelve-month target prices for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $315.00. On average, they expect the company's share price to reach $268.92 in the next year. This suggests a possible upside of 33.1% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 on January 1st, 2023. Since then, TFX shares have decreased by 19.1% and is now trading at $202.00.
View the best growth stocks for 2023 here
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our TFX earnings forecast
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) posted its earnings results on Thursday, August, 3rd. The medical technology company reported $3.41 EPS for the quarter, beating analysts' consensus estimates of $3.21 by $0.20. The medical technology company had revenue of $743.30 million for the quarter, compared to analyst estimates of $729.87 million. Teleflex had a trailing twelve-month return on equity of 15.48% and a net margin of 12.71%. The firm's revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.39 earnings per share.
Read the conference call transcript
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, August 3rd. Investors of record on Friday, September 15th will be paid a dividend of $0.34 per share on Friday, September 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Thursday, September 14th.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.67%. The dividend payout ratio is 17.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY23 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of $13.00-13.60 for the period, compared to the consensus estimate of $13.29. The company issued revenue guidance of +5.8%-6.55% to $2.93-2.97 billion, compared to the consensus revenue estimate of $2.94 billion.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.43%), State Street Corp (5.03%), Geode Capital Management LLC (2.11%), Allspring Global Investments Holdings LLC (1.37%), Bessemer Group Inc. (1.17%) and TD Asset Management Inc (1.00%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $202.00.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $9.49 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.79 on an earnings per share basis.

How many employees does Teleflex have?

The company employs 15,500 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -